Exploring the link between sleep apnea, facial discoloration, and fainting symptoms.
Clinical Association Between Obstructive Sleep Apnea (OSA) and Facial Pigmentation, and the Relation Between OSA and Vasovagal Symptoms With Resulting Smoking Tendency and the Effect of Treatment in Patients Referred for Sleep Study.
This study is trying to see if changes in facial color can help identify sleep apnea in people who also experience fainting symptoms and smoke.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Jordan Collaborating Cardiology Group Academic / other |
| Locations | 1 site (Amman) |
| Trial ID | NCT06331819 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather demographic and clinical data from patients referred for sleep studies at the Jordan University Hospital and other locations. It will assess the diagnostic value of facial discoloration as a potential indicator of obstructive sleep apnea (OSA) and explore the relationship between OSA, vasovagal symptoms, and smoking tendencies. Participants will undergo polysomnography and will be followed up to evaluate treatment outcomes and symptom improvement over time.
Who should consider this trial
Good fit: Ideal candidates include individuals referred for sleep studies who are within the specified age range and consent to participate.
Not a fit: Patients with a prior diagnosis of obstructive sleep apnea will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the detection of obstructive sleep apnea and improve management strategies for patients exhibiting related symptoms.
How similar studies have performed: While the approach of correlating facial discoloration with obstructive sleep apnea is relatively novel, similar studies have shown promise in identifying diagnostic markers for sleep disorders.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients within age limit who agree to participate and sign the consent form. Exclusion Criteria: * Patients with prior diagnosis of obstructive sleep apnea by sleep study.
Where this trial is running
Amman
- The University of Jordan — Amman, Jordan (Recruiting)
Study contacts
- Principal investigator: Rand M Zaqqa — Jordan University Hospital
- Study coordinator: Rand M Zaqqa
- Email: rand.zaqqa@outlook.com
- Phone: 00962799550746
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.